Venture Visionary Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Venture Visionary Partners LLC

  • $2.25 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
BUY
$548.35 - $738.84 $93,219 - $125,602
170 New
170 $100,000
Q1 2022

May 03, 2022
SELL
$595.12 - $698.43 $970,045 - $1.14 Million
-1,630 Closed
0 $0
Q4 2021

Feb 08, 2022
SELL
$543.48 - $670.97 $28,260 - $34,890
-52 Reduced 3.09%
1,630 $1.03 Million
Q3 2021

Oct 20, 2021
BUY
$574.03 - $680.96 $117,102 - $138,915
204 Added 13.8%
1,682 $1.02 Million
Q2 2021

Aug 05, 2021
BUY
$472.8 - $558.54 $698,798 - $825,522
1,478 New
1,478 $825,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email